CDOYX | RMEBX | CDOYX / RMEBX | |
Total Expense Ratio | 0.74 | 1.07 | 69% |
Annual Report Gross Expense Ratio | 0.74 | 1.07 | 69% |
Fund Existence | 13 years | 11 years | - |
Gain YTD | 8.209 | 10.612 | 77% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 250 | 400,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.14B | 110B | 2% |
Annual Yield % from dividends | 2.80 | 1.11 | 253% |
Returns for 1 year | 6.75 | 7.63 | 88% |
Returns for 3 years | 16.66 | 22.19 | 75% |
Returns for 5 years | 43.78 | 53.85 | 81% |
Returns for 10 years | 40.24 | 77.43 | 52% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PHPIX | 26.43 | 0.19 | +0.72% |
ProFunds Pharmaceuticals UltraSector Inv | |||
AEDCX | 32.59 | 0.08 | +0.25% |
Invesco EQV European Equity C | |||
FMILX | 66.22 | -0.21 | -0.32% |
Fidelity New Millennium | |||
ASCRX | 15.68 | -0.05 | -0.32% |
American Century Small Company R | |||
FISVX | 25.90 | -0.19 | -0.73% |
Fidelity Small Cap Value Index |